Governing Molecular Tumor Boards: Precision Funnel Analysis, Outcome Gap, and a Pay-at-Result Reform Framework - Evidence from a Nationally Mandated Programme.
Systematic accountability frameworks for precision oncology tumor boards could ensure genetic testing recommendations translate to real patient benefits.
PURPOSE: Molecular Tumor Boards (MTBs) are widely implemented in precision oncology, yet no health system has established a mandatory outcome accountability framework. Each reform is grounded in operational precedents: the UK Cancer Drugs Fund, the French Accès Précoce mechanism, and the German MASTER trial network.
What the study was
- Study design
- Observational/unspecified
- Population
- cancer patients
- Sample size
- 12176
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Journal of cancer policy
Why it surfaced
Score 6/10 [PROMISING_PRELIMINARY]: Observational/unspecified (Journal Article) matched 'Precision oncology and genomic medicine'. Components — novelty:1/3, relevance:3/3, design:1/2, population:1/2. Confidence: medium. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.